Our previous data on IL-32θ, a recently discovered isoform, demonstrated its inhibition ability in macrophage differentiation [32], macrophage-secreted factors [16, 18, 19], and in colon cancer progression by regulating self-renewal and EMT [17]. Here, IL32 is linked to colonic neoplasm.